Neonatal sepsis and antimicrobial resistance
Randomized trial of intravenous fosfomycin to treat neonatal sepsis: safety and pharmacokinetics. Determining antimicrobial usage in neonates and fecal carriage and acquisition of antimicrobial resistance. Microbiological surveillance of neonatal sepsis. Molecular detection of causes of neonatal sepsis.
Countries
Active Dates
08/01/2018 to 06/30/2021
Faculty Involved